Clinical Trials in North Carolina

Showing 2981-3000 of 9,731 trials

The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.

NCT05088694

Researcher from UNC Greensboro have partnered with Prevention Strategies and key stakeholders from the Kingdom of Bahrain to conduct a study using the innovative, engineering-inspired methodological approach, the Multiphase Optimization Strategy (MOST), to optimize and evaluate the Peaceful Coexistence and Anti-Extremism middle and high school curricula. No other curriculum targeting tolerance and/or extremism has been optimized using the state-of-the-art MOST methodology. The overall goal of the project is that the optimized versions of Peaceful Coexistence and Anti-Extremism curricula will be used across the Kingdom of Bahrain and translated for use in other countries to combat the spread of extremism and intolerance. Additionally, the D.A.R.E. keepin' it REAL (kiR) and D.A.R.E. myPlaybook high school programs will be evaluated as part of the Peaceful Coexistence and Anti-Extremism evaluation.

Norm, SocialLiteracyResistance Skills+7 more

University of North Carolina, Greensboro1,500 participantsStarted Nov 2021

Greensboro, North Carolina, United States

COMPLETEDPhase 231 miles

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

NCT01889238

The purpose of this study is to determine if enzalutamide is safe and effective in the treatment of patients with advanced breast cancer that express the androgen receptor but do not express the estrogen or progesterone receptor and are not Her2 amplified.

Advanced, Androgen Receptor Positive Triple Negative Breast Cancer

Pfizer118 participantsStarted Jun 2013

Colorado Springs, Colorado, United States • Lakewood, Colorado, United States • Lone Tree, Colorado, United States +129 more locations

The Optimization and Evaluation of the Extremism and Intolerance Curriculum for the Kingdom of Bahrain.

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Find Trials by Condition in North Carolina

Postpartum Glycemia in Women At Risk for Persistent Hyperglycemia

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Endovascular Engineering ENGULF Study

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films

A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

CYPRESS Efficacy and Safety Study Extension

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Nitrous Oxide for the Treatment of Major Depressive Disorder